ロード中...
Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian Cancer
SIMPLE SUMMARY: Recurrent ovarian cancer is difficult to treat due to the development of chemotherapy resistance. This resistance develops through multiple mechanisms to include the avoidance of cell death by cancer cells. Prior studies have shown birinapant, a second mitochondrial activator of casp...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7765376/ https://ncbi.nlm.nih.gov/pubmed/33334024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12123784 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|